首页> 外文期刊>Langmuir: The ACS Journal of Surfaces and Colloids >Interaction of Endothelial and Smooth Muscle Cells with Cobalt?Chromium Alloy Surfaces Coated with Paclitaxel Deposited Self-Assembled Monolayers
【24h】

Interaction of Endothelial and Smooth Muscle Cells with Cobalt?Chromium Alloy Surfaces Coated with Paclitaxel Deposited Self-Assembled Monolayers

机译:内皮细胞和平滑肌细胞与紫杉醇沉积自组装单层钴铬合金表面的相互作用

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The use of self-assembled monolayers (SAMs) as a polymer-free platform to deliver an antiproliferative drug, paclitaxel (PAT), from a stent material cobalt?chromium (CoCr) alloy has been previously demonstrated. In this study, the interaction of human aortic endothelial cells (ECs) and human aortic smooth muscle cells (SMCs) with CoCr alloy surfaces coated with SAMs-(SAMs-CoCr) and PAT-deposited SAMs (PAT-SAMs-CoCr) was investigated. A polished CoCr with no coatings was used as a control. The viability, proliferation, morphology, and phenotype of ECs and SMCs were investigated on these samples. SAMs-CoCr significantly enhanced the growth of ECs. Also, the ECs were well spreading with its typical morphological features and showed stronger PECAM-1 expression on SAMs-CoCr. This showed that the SAMs-CoCr surface is conducive to endothelialization. For PAT-SAMs-CoCr, although the adhesion of ECs was lower, the cells continued to proliferate with some degree of spreading and limited PECAM-1 expression. For SMCs, a significant decrease in the cell proliferation was observed on SAMs-CoCr when compared with that of Control-CoCr. PAT-SAMs-CoCr showed maximum inhibitory effect on the proliferation of SMCs. Also, the SMCs on PAT-SAMs-CoCr displayed a poorly spread discoid morphology with disarranged α-actin filaments. This showed that the PAT released from the SAMs platform successfully inhibited the growth of SMCs. Thus, this study showed the interaction of ECs and SMCs with SAMs-CoCr and PAT-SAMs-CoCr for potential uses in stents and other cardiovascular medical devices.
机译:先前已经证明了使用自组装单分子膜(SAMs)作为无聚合物平台从支架材料钴铬(CoCr)合金中释放出抗增殖药紫杉醇(PAT)。在这项研究中,研究了人主动脉内皮细胞(ECs)和人主动脉平滑肌细胞(SMCs)与涂有SAMs-(SAMs-CoCr)和PAT沉积的SAMs(PAT-SAMs-CoCr)的CoCr合金表面的相互作用。没有涂层的抛光CoCr用作对照。在这些样品上研究了EC和SMC的活力,增殖,形态和表型。 SAMs-CoCr显着增强了EC的生长。此外,ECs以其典型的形态学特征很好地传播,并在SAMs-CoCr上显示出更强的PECAM-1表达。这表明SAMs-CoCr表面有利于内皮化。对于PAT-SAMs-CoCr,尽管EC的粘附力较低,但细胞继续增殖,并具有一定程度的扩散和有限的PECAM-1表达。对于SMC,与对照-CoCr相比,在SAMs-CoCr上观察到细胞增殖显着降低。 PAT-SAMs-CoCr对SMC的增殖表现出最大的抑制作用。同样,PAT-SAMs-CoCr上的SMC显示盘状形态分布较差,α-肌动蛋白丝排列不规则。这表明从SAMs平台释放的PAT成功抑制了SMC的生长。因此,这项研究表明EC和SMC与SAMs-CoCr和PAT-SAMs-CoCr的相互作用可用于支架和其他心血管医疗设备。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号